Charles Schwab Investment Management Inc. Invests $875,000 in TruBridge, Inc. (NASDAQ:TBRG)

Charles Schwab Investment Management Inc. purchased a new stake in shares of TruBridge, Inc. (NASDAQ:TBRG) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 73,163 shares of the company’s stock, valued at approximately $875,000. Charles Schwab Investment Management Inc. owned approximately 0.49% of TruBridge at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in TBRG. GSA Capital Partners LLP bought a new position in TruBridge during the third quarter valued at about $389,000. GAMMA Investing LLC purchased a new stake in shares of TruBridge during the 3rd quarter worth approximately $26,000. Oppenheimer Asset Management Inc. purchased a new position in TruBridge in the third quarter valued at approximately $309,000. CacheTech Inc. bought a new position in TruBridge during the third quarter valued at $2,875,000. Finally, Cubist Systematic Strategies LLC purchased a new stake in TruBridge in the second quarter worth $740,000. 88.64% of the stock is currently owned by hedge funds and other institutional investors.

TruBridge Price Performance

TruBridge stock opened at $18.09 on Wednesday. The stock has a market cap of $269.99 million, a price-to-earnings ratio of -4.42, a PEG ratio of 70.25 and a beta of 0.69. The company has a quick ratio of 1.78, a current ratio of 1.80 and a debt-to-equity ratio of 1.00. The business has a 50-day simple moving average of $15.14 and a 200 day simple moving average of $12.66. TruBridge, Inc. has a 52 week low of $7.55 and a 52 week high of $18.80.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on TBRG. Royal Bank of Canada reiterated an “outperform” rating and set a $14.00 target price on shares of TruBridge in a research report on Tuesday, September 17th. Stephens lifted their price target on TruBridge from $13.00 to $17.00 and gave the company an “equal weight” rating in a research report on Wednesday, November 20th. Cantor Fitzgerald reissued an “overweight” rating and set a $13.00 price objective on shares of TruBridge in a report on Friday, October 4th. Finally, Barclays upped their price target on TruBridge from $10.00 to $14.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th.

Insider Buying and Selling

In other TruBridge news, Director Mark V. Anquillare purchased 2,500 shares of the firm’s stock in a transaction on Monday, November 25th. The shares were purchased at an average cost of $16.81 per share, with a total value of $42,025.00. Following the completion of the purchase, the director now owns 17,178 shares of the company’s stock, valued at $288,762.18. The trade was a 17.03 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, major shareholder Pinetree Capital Ltd. bought 3,997 shares of the firm’s stock in a transaction that occurred on Wednesday, October 2nd. The stock was acquired at an average price of $11.93 per share, for a total transaction of $47,684.21. Following the transaction, the insider now owns 603,997 shares in the company, valued at $7,205,684.21. This trade represents a 0.67 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.60% of the stock is owned by company insiders.

TruBridge Profile

TruBridge, Inc provides healthcare solutions and services for community hospitals, clinics, and other healthcare systems in the United States and internationally. The company operates in three segments: Revenue Cycle Management (RCM), Electronic Health Record (HER), and Patient Engagement. It focuses on providing RCM solutions for care settings, regardless of primary healthcare information solutions provider along with business management, consulting, managed IT services, and analytics and business intelligence.